ADC Therapeutics SA
(NYSE : ADCT)

( )
ADCT PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Co.
2.49%61.451.4%$1588.69m
JNJJohnson & Johnson
0.56%140.340.7%$880.30m
PFEPfizer Inc.
-0.03%38.290.9%$769.00m
MRKMerck & Co., Inc.
0.45%89.240.7%$673.36m
ABBVAbbVie, Inc.
1.09%87.952.3%$656.92m
LLYEli Lilly & Co.
-0.14%119.601.1%$340.88m
AZNAstraZeneca Plc
-0.38%47.501.2%$135.78m
RETAReata Pharmaceuticals, Inc.
-0.12%199.323.5%$133.57m
GSKGlaxoSmithKline Plc
-0.29%45.380.2%$128.24m
NVSNovartis AG
0.01%91.960.2%$128.18m
KRTXKaruna Therapeutics, Inc.
3.35%67.630.0%$101.66m
NVONovo Nordisk A/S
-0.41%56.500.1%$92.38m
SNYSanofi
-0.28%45.900.2%$69.78m
ALLKAllakos, Inc.
-4.63%117.360.0%$64.39m
BHVNBiohaven Pharmaceutical Holding Co. Ltd.
2.05%54.860.0%$38.47m

Company Profile

ADC Therapeutics Sarl develops antibody drug conjugates (ADCs) and non-antibody drug conjugate products. The company is based in Lausanne, Switzerland. ADC Therapeutics Sarl operates as a subsidiary of Celtic Therapeutics Holdings L.P.